On 2 March 2022, Zhongshan Chenxinghai Hospital, Hong Kong Integrated Oncology Centre (HKIOC), and DCH Auriga announced the strategic cooperation in support of a National State Council initiative to provide Hong Kong-approved medical treatments to Greater Bay Area (GBA) patients.
Under the strategic partnership, DCH Auriga and HKIOC will support…
Auriga News
THE BIG DAY! The arrival of Fosun Pharma BioNTech's COMIRNATY Covid-19 vaccines on 27 February, 2021
Auriga News
DCH Auriga being exclusive distributor of BioNTech Covid-19 vaccine in Hong Kong
Auriga News
DCH Auriga announced as a 2018 JDA Real Results Awards Winner for Best Results APAC
Auriga News
DCH Auriga continues its momentum with JDA’s state-of-the-art Warehouse Management System
Setting new standards in healthcare supply chain agility and visibility
Auriga News
DCH Auriga Singapore promotes & distributes both Pharmaceutical & Oncology Medicines for Novartis (Singapore) Pte Ltd
DCH Auriga Singapore is pleased to be the chosen partner by Novartis (Singapore) Pte Ltd to promote